Global Health Investor Presentation: Key Takeaways
Global Health (Medanta) delivered Q1 FY27 revenue growth of 26% YoY to INR 13,262 million, driven by robust patient volumes and scaling of the Noida facility.
ALFA Filings
Every announcement, straight from the exchange
Every Global Health earnings call announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Global Health (Medanta) delivered Q1 FY27 revenue growth of 26% YoY to INR 13,262 million, driven by robust patient volumes and scaling of the Noida facility.
Global Health (Medanta) delivered strong 26% revenue growth, fueled by higher patient volumes and a rapid turnaround in the new Noida facility.
Global Health (Medanta) reported 26.2% YoY revenue growth in Q1 FY27, driven by strong patient volumes and narrowing losses at the Noida facility.
Global Health Limited reported FY26 total income growth of 20% to ₹45,089 million with consolidated PAT up 15.1% to ₹5,541 million. Growth was driven by patient volume increases and scaling of developing hospitals.
Medanta delivered a robust FY26 with 20% revenue growth, driven by rapid ramp-up in Noida and maturity in Lucknow/Patna. Management is balancing high-intensity expansion with maintained 24-25% EBITDA margins.
Global Health (Medanta) reported strong FY26 performance with 20% revenue growth and 15% PAT growth. Expansion continues with Noida facility now operational and new projects in Varanasi and Indore.